Document Detail


Ultrarush immunotherapy in a patient with occupational allergy to bumblebee venom (Bombus terrestris).
MedLine Citation:
PMID:  16433215     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Bumblebee venom allergies, though uncommon among the broad public, pose a significant risk in plant industry and scientific occupation. Since a significant IgE cross-reactivity between bumblebee and honeybee venom has been described in several cases and bumblebee venom for immunotherapy has been available only from a few suppliers, SIT with honeybee venom was frequently used for bumblebee venom allergic patients in the past. We present the case of occupational bumblebee allergy in a biologist who developed anaphylactic reactions with subsequent stings. He was lacking cross-reactivity to honeybee venom, therefore we initiated immunotherapy with bumblebee venom extract. Two months after reaching the maintenance dose of 80 microg, the efficacy of the treatment was demonstrated by sting challenge.
Authors:
A Roll; P Schmid-Grendelmeier
Related Documents :
22795075 - Life after failure of traditional androgen deprivation therapy.
2376435 - Investigation of a testicular cancer cluster using a case-control approach.
21422235 - Mns16a tandem repeats minisatellite of human telomerase gene: a risk factor for colorec...
18064535 - Nested case-control study of occupational physical activity and prostate cancer among w...
19166905 - The dynamic and static modification of the epigenome by hormones: a role in the develop...
22496695 - Fertility preservation in girls.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Journal of investigational allergology & clinical immunology : official organ of the International Association of Asthmology (INTERASMA) and Sociedad Latinoamericana de Alergia e Inmunología     Volume:  15     ISSN:  1018-9068     ISO Abbreviation:  J Investig Allergol Clin Immunol     Publication Date:  2005  
Date Detail:
Created Date:  2006-01-25     Completed Date:  2006-04-07     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9107858     Medline TA:  J Investig Allergol Clin Immunol     Country:  Spain    
Other Details:
Languages:  eng     Pagination:  305-7     Citation Subset:  IM    
Affiliation:
Allergy Unit, Department of Dermatology, University Hospital, Zurich, Switzerland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Animals
Bee Venoms / administration & dosage,  immunology*
Bees
Histamine H1 Antagonists / administration & dosage
Humans
Hypersensitivity, Immediate / immunology,  therapy*
Immunoglobulin E / immunology
Immunotherapy* / adverse effects
Insect Bites and Stings / immunology
Male
Chemical
Reg. No./Substance:
0/Bee Venoms; 0/Histamine H1 Antagonists; 37341-29-0/Immunoglobulin E

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Delayed selective reaction to clavulanic acid: a case report.
Next Document:  Latex-vegetable syndrome due to custard apple and aubergine: new variations of the hevein symphony.